Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Benign Hematology. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

featured
Published in Benign Hematology and
1 other channel

Journal Scan / Research · August 04, 2022

Comparing Antithrombotic Therapies After ACS or PCI in Patients With AF and Prior Stroke

JAMA Cardiology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Niccolò Bonini MD

Hizir Ozdemir MD

JAMA Cardiology
Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial
JAMA Cardiol 2022 May 25;[EPub Ahead of Print], MC Bahit, AN Vora, Z Li, DM Wojdyla, L Thomas, SG Goodman, R Aronson, JD Jordan, BJ Kolls, KE Dombrowski, D Vinereanu, S Halvorsen, O Berwanger, S Windecker, R Mehran, CB Granger, JH Alexander, RD Lopes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated